HBI Deals+Insights / Payor and Operator Models
GLP-1 weight loss drugs are now widely used in the UK, with around 2.5 million people taking them. The market has grown fast, raising questions about how safely these medications are prescribed and how much support patients receive. NHS access is still limited and varies depending on where you live. As a result, many people are choosing to go private.





